Black FridayDo 80% ZNIŻKI
AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

Brak transakcji
Zobacz na Superwykresach
PrzeglądFinansePomysłyPrzemyśleniaDane techniczneSezonowośćObligacje

Obligacje

Poniżej znajduje się lista obligacji korporacyjnych AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol
YTM %
Wolumen
Cena %
Kupon %
Termin zapadalności
Kwota niezapłacona
Wartość nominalna
Min. kw. nominału
Emitent
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7,00%26 K76,04%4,750%2045-03-1553,51 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
XS190919331Allergan Funding SCS 2.625% 15-NOV-2028
6,50%089,79%2,625%2028-11-1572,11 M EUR1 000,00 EUR100 000,00 EURAllergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6,40%12 K83,25%4,850%2044-06-1565,23 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6,38%124 K81,98%4,625%2042-10-0167,49 M USD1 000,00 USD2 000,00 USDActavis, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,53%9,87 M99,50%5,500%2064-03-151,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAW9AbbVie Inc. 4.45% 14-MAY-2046
5,50%087,20%4,450%2046-05-142 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,49%26 K90,47%3,200%2029-11-2162,52 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABBAbbVie Inc. 4.7% 14-MAY-2045
5,47%090,80%4,700%2045-05-142,7 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
5,47%750 K101,89%5,600%2055-03-15750 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,44%1,04 M91,72%4,750%2045-03-15827,09 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,43%4,93 M84,20%4,250%2049-11-215,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,43%22,87 M99,49%5,400%2054-03-153 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,40%452 K93,11%4,875%2048-11-141,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,32%543 K94,49%4,850%2044-06-151,01 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,30%10,11 M92,51%4,625%2042-10-01389,22 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5,27%10 K94,75%4,550%2035-03-15107,65 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5,23%5,09 M90,73%4,400%2042-11-062,6 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,20%5,81 M101,69%5,350%2044-03-15750 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,00%10,88 M90,49%4,050%2039-11-214 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAV1AbbVie Inc. 4.3% 14-MAY-2036
4,80%095,87%4,300%2036-05-141 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAR0AbbVie Inc. 4.5% 14-MAY-2035
4,72%098,29%4,500%2035-05-142,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
4,63%3,74 M104,25%5,200%2035-03-151 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4,59%1,47 M99,72%4,550%2035-03-151,68 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4,52%7 M103,65%5,050%2034-03-153 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029
4,29%093,05%2,125%2029-06-0136,46 M EUR1 000,00 EUR100 000,00 EURAllergan Funding SCS
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,12%7,16 M103,91%4,950%2031-03-152 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAY5AbbVie Inc. 3.2% 14-MAY-2026
4,08%099,61%3,200%2026-05-142 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
4,01%3,08 M103,37%4,875%2030-03-151 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,00%16,72 M97,07%3,200%2029-11-215,44 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
3,90%1,76 M102,76%4,800%2029-03-152,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
3,87%6,11 M101,18%4,800%2027-03-152,25 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
3,84%7,13 M101,12%4,250%2028-11-141,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
3,84%3,99 M101,76%4,650%2028-03-151,25 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
3,83%66,98 M99,16%2,950%2026-11-213,99 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3,16%0126,76%4,750%2045-03-155 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
3,13%0128,71%4,850%2044-06-15100 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3,13%0121,31%4,250%2049-11-214,95 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABGAbbVie Inc. 1.25% 18-NOV-2031
2,92%090,95%1,250%2031-11-18650 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS212591491AbbVie Inc. 2.125% 01-JUN-2029
2,67%098,18%2,125%2029-06-01506,09 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS152090781AbbVie Inc. 2.125% 17-NOV-2028
2,59%098,69%2,125%2028-11-17750 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,57%0123,74%4,550%2035-03-151 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
XS212591483AbbVie Inc. 2.625% 15-NOV-2028
2,56%0100,20%2,625%2028-11-15427,79 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
4ABEAbbVie Inc. 0.75% 18-NOV-2027
2,47%096,71%0,750%2027-11-18750 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
−5,92%0111,17%2,950%2026-11-219,24 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4,400%2042-11-061,1 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
Utwórz więcej list w Skanerze